semaglutide off the market India's obesity and diabetes drug is on verge of taking off. Semaglutide, the molecule behind Ozempic and Wegovy will go patent this Saturday paving the way for low-cost generic drugs US judge upholds FDA's removal

Europe Market Split by Country The GLP-1 diabetes treatment drugs market in Europe is projected to grow from USD 1,708.0 million in 2025 to USD 14,836.7 million by 2035, registering a CAGR of 23.3% over the forecast period

Eli Lillys December 2025 press release reported average weight loss of up to 71.2 lbs at the highest dose, alongside substantial relief from osteoarthritis pain

Also watch for symptoms of gallbladder disease (right upper quadrant pain, fever, jaundice), which has been associated with GLP-1 medications and weight loss

Vilsbll, Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

Thats why our Texas Virtual Weight Loss Program is designed to fit your schedule, with safe, convenient access to trusted GLP-1 prescriptions from a local team that truly cares

Spread high-fiber foods across the day rather than concentrating them in one meal